In December 2025, the Joint Panel on Multidistrict Litigation (JPML) chose to centralize lawsuits filed by people who say Saxenda and other GLP-1 drugs caused them to develop NAION
Su frmula avanzada, enriquecida con ingredientes de alta calidad,
Conflicto de intereses Participacin en actividades docentes financiadas por Laboratorios Novo Nordisk, Laboratorios Lilly y Laboratorios Boehringer Ingelheim, llevadas a cabo como coordinador, ponente o moderador de reuniones cientficas
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: a systematic review and meta-analysis of controlled trials
Where to inject Saxenda Saxenda can be injected into three areas of the body: Abdomen , at least two inches away from the navel Front of the thigh Back of the upper arm (typically requires assistance) Rotate injection sites each day to reduce the risk of skin reactions or lipohypertrophy (firm or fatty lumps that can develop with repeated injections in the same area)